Speaking to PharmaDispatch yesterday, and following recently announced changes to its Board and Canberra-based secretariat, CEO Liz de Somer said the association's goal is to build a 'renewed momentum'.
MA's Liz de Somer: 'Critical' to build a 'renewed momentum'
August 2, 2018 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Patient voices take centre stage at the 2026 Patient's Choice Awards
June 3, 2026 - - Latest News -
Officials confirm shift in Budget management of underspends
June 3, 2026 - - Latest News -
Invitation confusion clouds Delphi studies and captures medical device sector
June 3, 2026 - - Latest News -
Omico opens a new chapter in precision oncology research
June 1, 2026 - - Latest News -
Ex-MA executive named the first CEO of Medicinal Cannabis Council Australia
June 1, 2026 - - Latest News -
Oral RAS inhibitor doubles median survival and cuts death risk in metastatic pancreatic cancer
June 1, 2026 - - Latest News -
Australia risks losing more than jobs in its biopharmaceutical sector — it risks losing strategic capability
June 1, 2026 - - Latest News

